Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer
Yufan Ying et al.
CELL PROLIFERATION (2020)
miR-451a is downregulated and targets PSMB8 in prostate cancer
Yun Liu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)
ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer
Jie Yao et al.
AGING-US (2020)
LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p
Lin Yu et al.
THORACIC CANCER (2020)
MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
Li Tao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization
Jae Young So et al.
CANCER RESEARCH (2020)
Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
Shiyu Mao et al.
ONCOTARGETS AND THERAPY (2020)
Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer
Simone Buraschi et al.
MATRIX BIOLOGY (2020)
MiR-451a restrains the growth and metastatic phenotypes of papillary thyroid carcinoma cells via inhibiting ZEB1
Qiong Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B
Rabah B. Zo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?
Joya-Rita Hindy et al.
FUTURE ONCOLOGY (2019)
FEN1 mediates miR-200a methylation and promotes breast cancer cell growth via MET and EGFR signaling
Xue Zeng et al.
FASEB JOURNAL (2019)
Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2
Jing-hui Tian et al.
JOURNAL OF VIRAL HEPATITIS (2019)
A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression
C. Chang et al.
ONCOGENE (2018)
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer
Maolin Chu et al.
SCIENTIFIC REPORTS (2018)
EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers
Mariangela De Robertis et al.
MOLECULAR CANCER (2018)
lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA
Mengxin Lv et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling
X. Xu et al.
CELL DEATH & DISEASE (2016)
Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer
R. Matsushita et al.
BRITISH JOURNAL OF CANCER (2015)
Clinical and pathological implications of miRNA in bladder cancer
Cornelia Braicu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: Its potential use in the treatment of bladder cancers
Nadine Houede et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Methylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
Takashi Shimizu et al.
EUROPEAN UROLOGY (2013)
MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein
Zhihong Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
Manish Tandon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
Christina Barbara Ching et al.
LABORATORY INVESTIGATION (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Share Paper
